z-logo
open-access-imgOpen Access
Balancing RAF, MEK, and EGFR Inhibitor Doses to Achieve Clinical Responses and Modulate Toxicity in BRAF V600E Colorectal Cancer
Author(s) -
Sebastián Mondaca,
Mario E. Lacouture,
Jonathan Hersch,
Rona Yaeger
Publication year - 2018
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.18.00088
Subject(s) - colorectal cancer , toxicity , egfr inhibitors , medicine , mek inhibitor , pharmacology , cancer research , cancer , epidermal growth factor receptor , chemistry , mapk/erk pathway , phosphorylation , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom